Nalaganje...
Structure and Optimization of Checkpoint Inhibitors
With the advent of checkpoint inhibitor treatment for various cancer types, the optimization of drug selection, pharmacokinetics and biomarker assays is an urgent and as yet unresolved dilemma for clinicians, pharmaceutical companies and researchers. Drugs which inhibit cytotoxic T-lymphocyte associ...
Shranjeno v:
| izdano v: | Cancers (Basel) |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7017177/ https://ncbi.nlm.nih.gov/pubmed/31877721 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12010038 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|